Search research articles
Contact Us
Filters
Showing results (181-190 of 193) with videos related to
Page
of 20
Sort By:
Leukemia
|
September 19, 2025
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study
Andrea Visentin, Enrico Gaffo, Moritz Fürstenau, et al.
Journal of Hematology & Oncology
|
July 21, 2025
Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study
Eleonora Roncaglia, Enrico Gaffo, Giulia Calabretto, et al.
Haematologica
|
June 26, 2025
Rethinking the feasibility and safety of venetoclax-obinutuzumab in chronic lymphocytic leukemia: non-traditional factors may play a role in clinical practice
Anna Maria Frustaci, Andrea Galitzia, Mariano Lucignano, et al.
Blood Advances
|
October 24, 2025
Central Nervous System Involvement in CLL: An International Retrospective Study by ERIC, the European Research Initiative on CLL
Thomas Chatzikonstantinou, Mariia Mikhaleva, Christian Brieghel, et al.
Leukemia
|
June 30, 2025
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms
Ferran Nadeu, Shimin Shuai, Guillem Clot, et al.
Blood
|
September 29, 2020
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
Andreas Agathangelidis, Anastasia Chatzidimitriou, Katerina Gemenetzi, et al.
Hematological Oncology
|
December 29, 2025
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study
Ernesto Vigna, Enrica Antonia Martino, Annalisa Pitino, et al.
Blood Advances
|
January 7, 2026
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian Cohort
Enrica Antonia Martino, Annalisa Pitino, Ernesto Vigna, et al.
Journal of Hematology & Oncology
|
August 26, 2022
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL
Darko Antic, Natasa Milic, Thomas Chatzikonstantinou, et al.
Leukemia
|
November 2, 2021
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 193) with videos related to
Sort By:
Page
of 20
Leukemia
|
September 19, 2025
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study
Andrea Visentin, Enrico Gaffo, Moritz Fürstenau, et al.
Journal of Hematology & Oncology
|
July 21, 2025
Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study
Eleonora Roncaglia, Enrico Gaffo, Giulia Calabretto, et al.
Haematologica
|
June 26, 2025
Rethinking the feasibility and safety of venetoclax-obinutuzumab in chronic lymphocytic leukemia: non-traditional factors may play a role in clinical practice
Anna Maria Frustaci, Andrea Galitzia, Mariano Lucignano, et al.
Blood Advances
|
October 24, 2025
Central Nervous System Involvement in CLL: An International Retrospective Study by ERIC, the European Research Initiative on CLL
Thomas Chatzikonstantinou, Mariia Mikhaleva, Christian Brieghel, et al.
Leukemia
|
June 30, 2025
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms
Ferran Nadeu, Shimin Shuai, Guillem Clot, et al.
Blood
|
September 29, 2020
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
Andreas Agathangelidis, Anastasia Chatzidimitriou, Katerina Gemenetzi, et al.
Hematological Oncology
|
December 29, 2025
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study
Ernesto Vigna, Enrica Antonia Martino, Annalisa Pitino, et al.
Blood Advances
|
January 7, 2026
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian Cohort
Enrica Antonia Martino, Annalisa Pitino, Ernesto Vigna, et al.
Journal of Hematology & Oncology
|
August 26, 2022
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL
Darko Antic, Natasa Milic, Thomas Chatzikonstantinou, et al.
Leukemia
|
November 2, 2021
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò, et al.
Page
of 20